Skip to main content
. 2017 Oct 11;6:28. doi: 10.1186/s40164-017-0088-z

Fig. 1.

Fig. 1

Adverse factors including inhibitory cytokines, immune checkpoint molecules and hypoxia restrict CAR T cells from reaching an optimal anti-tumor capacity in the tumor microenvironment